BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation.
International experts reviewed current evidence and updated recommendations according …

BK virus maintains a latent infection that is ubiquitous in humans. It has a propensity for
reactivation in the setting of a dysfunctional cellular immune response and is frequently …

The present AST‐IDCOP guidelines update information on BK polyomavirus (BKP yV)
infection, replication, and disease, which impact kidney transplantation (KT), but rarely non …

BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated
diseases on opposite ends of the immune scale in kidney transplant recipients. The principle …

BK virus–associated nephropathy (BKVAN) causes renal allograft dysfunction. The current
management of BKVAN relies on pre-emptive adaptation of immunosuppression according …

Clinical application of biomarkers is an integral component of transplant care. Clinicians and
scientists alike are in search of better biomarkers than the current serologic (serum …

Human polyomaviruses cause a common childhood infection worldwide and typically elicit a
neutralizing antibody and cellular immune response, while establishing a dormant infection …

Reactivation of BK polyomavirus (BKPyV) can cause significant kidney and bladder disease
in immunocompromised patients. There are currently no effective, BKPyV-specific therapies …

BK polyomavirus-specific antibody and T-cell responses in ki... : Current Opinion in Infectious
Diseases BK polyomavirus-specific antibody and T-cell responses in kidney transplantation …

Kidney transplantation (KT) is the most effective way to decrease the high morbidity and
mortality of patients with end-stage renal disease. However, KT does not completely reverse …